Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

Europe - BIT:ICOS - IT0005455875 - Common Stock

12.2 EUR
+0.08 (+0.66%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICOS. ICOS was compared to 14 industry peers in the Personal Care Products industry. ICOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
ICOS had a positive operating cash flow in the past year.
ICOS had positive earnings in each of the past 5 years.
In the past 5 years ICOS always reported a positive cash flow from operatings.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of ICOS (4.71%) is worse than 64.29% of its industry peers.
ICOS's Return On Equity of 10.16% is on the low side compared to the rest of the industry. ICOS is outperformed by 64.29% of its industry peers.
With a Return On Invested Capital value of 9.59%, ICOS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ICOS had an Average Return On Invested Capital over the past 3 years of 9.32%. This is below the industry average of 12.12%.
The 3 year average ROIC (9.32%) for ICOS is below the current ROIC(9.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROIC 9.59%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ICOS (4.34%) is worse than 64.29% of its industry peers.
ICOS's Profit Margin has declined in the last couple of years.
ICOS has a Operating Margin (9.31%) which is in line with its industry peers.
ICOS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.84%, ICOS is doing worse than 92.86% of the companies in the same industry.
ICOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
ICOS has more shares outstanding than it did 5 years ago.
ICOS has a worse debt/assets ratio than last year.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.46 indicates that ICOS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.46, ICOS is in line with its industry, outperforming 57.14% of the companies in the same industry.
The Debt to FCF ratio of ICOS is 16.66, which is on the high side as it means it would take ICOS, 16.66 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ICOS (16.66) is worse than 92.86% of its industry peers.
ICOS has a Debt/Equity ratio of 0.52. This is a neutral value indicating ICOS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, ICOS is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Altman-Z 3.46
ROIC/WACC1.41
WACC6.8%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.67 indicates that ICOS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.67, ICOS is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
ICOS has a Quick Ratio of 1.03. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, ICOS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.03
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.80% over the past year.
Measured over the past 5 years, ICOS shows a small growth in Earnings Per Share. The EPS has been growing by 1.57% on average per year.
ICOS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.02%.
Measured over the past years, ICOS shows a quite strong growth in Revenue. The Revenue has been growing by 8.36% on average per year.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%

3.2 Future

Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.63% on average per year.
ICOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y4.55%
EPS Next 2Y10.86%
EPS Next 3Y11.63%
EPS Next 5YN/A
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.90, ICOS is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of ICOS is on the same level as its industry peers.
ICOS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 15.67 indicates a correct valuation of ICOS.
78.57% of the companies in the same industry are more expensive than ICOS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, ICOS is valued a bit cheaper.
Industry RankSector Rank
PE 24.9
Fwd PE 15.67
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ICOS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 78.57% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICOS is valued more expensive than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 75.06
EV/EBITDA 8.33
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.48
PEG (5Y)15.85
EPS Next 2Y10.86%
EPS Next 3Y11.63%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.63%, ICOS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.86, ICOS is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.36, ICOS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

38.09% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP38.09%
EPS Next 2Y10.86%
EPS Next 3Y11.63%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (10/17/2025, 7:00:00 PM)

12.2

+0.08 (+0.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-06 2025-11-06
Inst Owners37.78%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.18B
Analysts86.67
Price Target17.39 (42.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.34%
EPS NY rev (3m)-8.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE 24.9
Fwd PE 15.67
P/S 1.08
P/FCF 75.06
P/OCF 13.14
P/B 2.53
P/tB 4.42
EV/EBITDA 8.33
EPS(TTM)0.49
EY4.02%
EPS(NY)0.78
Fwd EY6.38%
FCF(TTM)0.16
FCFY1.33%
OCF(TTM)0.93
OCFY7.61%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)5.48
PEG (5Y)15.85
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.16%
ROCE 14.65%
ROIC 9.59%
ROICexc 11.59%
ROICexgc 17.27%
OM 9.31%
PM (TTM) 4.34%
GM 19.84%
FCFM 1.44%
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexcg growth 3Y0.58%
ROICexcg growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 16.66
Debt/EBITDA 1.6
Cap/Depr 144.42%
Cap/Sales 6.77%
Interest Coverage 11.2
Cash Conversion 58.65%
Profit Quality 33.11%
Current Ratio 1.67
Quick Ratio 1.03
Altman-Z 3.46
F-Score7
WACC6.8%
ROIC/WACC1.41
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.55%
EPS Next 2Y10.86%
EPS Next 3Y11.63%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year2.69%
Revenue Next 2Y4.22%
Revenue Next 3Y4.75%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year72.17%
EBIT Next 3Y26.74%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%